Supernus Pharmaceuticals Ownership | Who Owns Supernus Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Supernus Pharmaceuticals Ownership Summary


Supernus Pharmaceuticals is owned by 108.27% institutional investors, 5.01% insiders. Blackrock is the largest institutional shareholder, holding 18.90% of SUPN shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.44% of its assets in Supernus Pharmaceuticals shares.

SUPN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSupernus Pharmaceuticals108.27%5.01%-13.29%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustrySpecialty & Generic Drug Manufacturers Stocks34.90%10.53%54.58%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock10.39M18.90%$278.00M
Vanguard group6.14M11.16%$164.18M
Armistice capital5.27M9.59%$141.03M
Dimensional fund advisors lp2.87M5.21%$76.69M
Macquarie group2.68M4.87%$71.69M
State street2.16M3.94%$57.88M
Polar capital1.94M3.53%$51.91M
Stephens investment management group1.90M3.45%$50.78M
Renaissance1.69M3.06%$45.08M
Loomis sayles & co l p1.56M2.83%$41.63M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ashford capital management711.89K2.57%$19.04M
Armistice capital5.27M1.77%$141.03M
Aristotle capital boston1.20M1.08%$32.18M
S&t bank/pa127.64K0.87%$3.41M
Third avenue management189.12K0.87%$5.06M
Rice hall james & associates502.59K0.81%$13.44M
Tributary capital management345.12K0.77%$9.23M
Bridge city capital82.28K0.74%$2.20M
Bruce82.11K0.72%$2.20M
Stephens investment management group1.90M0.71%$50.78M

Top Buyers

HolderShares% AssetsChange
Armistice capital5.27M1.77%1.70M
Pacer advisors1.35M0.08%1.35M
American century companies501.66K0.01%394.73K
Renaissance1.69M0.08%351.90K
Dimensional fund advisors lp2.87M0.02%309.97K

Top Sellers

HolderShares% AssetsChange
Woodline partners lp---1.29M
Congress asset management co /ma9.08K0.00%-1.02M
Pictet asset management sa545.90K0.02%-444.14K
Price t rowe associates inc /md/47.52K0.00%-395.23K
Congress wealth management llc / de /---177.80K

New Positions

HolderShares% AssetsChangeValue
Norges bank208.84K0.00%208.84K$5.59M
Candriam s.c.a.141.89K0.02%141.89K$3.80M
Marshall wace, llp73.52K0.00%73.52K$1.97M
Healthcare of ontario pension plan trust fund40.00K0.00%40.00K$1.07M
Corebridge financial29.33K0.00%29.33K$784.58K

Sold Out

HolderChange
Rfp financial group-27.00
Cape investment advisory-29.00
Valley national advisers-40.00
Nelson, van denburg & campbell wealth management group-46.00
First financial corp /in/-66.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202427211.02%59,712,0472.23%1080.96%13415.52%9012.50%
Jun 30, 2024245-3.54%58,410,9433.44%1061.00%1169.43%80-15.79%
Mar 31, 20242542.42%56,466,578-1.13%1030.94%106-10.17%957.95%
Dec 31, 20232483.33%57,110,8860.73%1040.97%1189.26%88-5.38%
Sep 30, 2023240-5.51%56,699,578-1.25%1030.94%108-10.74%934.49%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF3.55M6.44%1.83K
Delaware Small Cap Core I2.00M3.62%-12.37K
Pacer US Small Cap Cash Cows 100 ETF1.70M3.08%-888.00
Polar Capital Biotech S Inc1.70M3.07%-55.00K
Vanguard Total Stock Mkt Idx Inv1.66M3.01%-12.39K
Stephens SMID Select Growth1.39M2.52%101.68K
iShares Russell 2000 ETF1.39M2.52%-2.91K
Vanguard Small Cap Index1.31M2.38%2.55K
Vanguard Explorer Inv1.08M1.97%76.49K
Avantis US Small Cap Value ETF897.12K1.62%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 03, 2024Bhatt Padmanabh P. Sr. VP of IP, CSOSell$467.49K
Nov 11, 2024NEWHALL CHARLES W III-Sell$387.77K
Nov 08, 2024Hudson Frederick M.-Sell$316.43K
Nov 08, 2024GEMAYEL GEORGES-Sell$391.57K
Nov 08, 2024Khattar Jack A. President, CEOSell$4.54M

Insider Transactions Trends


DateBuySell
2024 Q4-8
2024 Q3-1
2024 Q1-8
2023 Q4-4
2023 Q3-2

SUPN Ownership FAQ


Who Owns Supernus Pharmaceuticals?

Supernus Pharmaceuticals shareholders are primarily institutional investors at 108.27%, followed by 5.01% insiders and -13.28% retail investors. The average institutional ownership in Supernus Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.90%, which Supernus Pharmaceuticals exceeds.

Who owns the most shares of Supernus Pharmaceuticals?

Supernus Pharmaceuticals’s largest shareholders are Blackrock (10.39M shares, 18.90%), Vanguard group (6.14M shares, 11.16%), and Armistice capital (5.27M shares, 9.59%). Together, they hold 39.66% of Supernus Pharmaceuticals’s total shares outstanding.

Does Blackrock own Supernus Pharmaceuticals?

Yes, BlackRock owns 18.90% of Supernus Pharmaceuticals, totaling 10.39M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 278M$. In the last quarter, BlackRock increased its holdings by 30.28K shares, a 0.29% change.

Who is Supernus Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Ashford capital management is Supernus Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.57% of its assets in 711.89K Supernus Pharmaceuticals shares, valued at 19.04M$.

Who is the top mutual fund holder of Supernus Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Supernus Pharmaceuticals shares, with 6.44% of its total shares outstanding invested in 3.55M Supernus Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools